aFAPF1_13 Industrial Pharmacy

Faculty of Pharmacy
Spring 2026

The course is not taught in Spring 2026

Extent and Intensity
2/0/0. 3 credit(s). Type of Completion: zk (examination).
Teacher(s)
doc. PharmDr. Aleš Franc, Ph.D. (lecturer)
PharmDr. Dominik Grega, Ph.D. (lecturer)
doc. RNDr. Jozef Kolář, CSc. (lecturer)
Mgr. Aleš Kroutil, Ph.D. (lecturer)
RNDr. Pavel Slanina (lecturer)
Guaranteed by
doc. PharmDr. Aleš Franc, Ph.D.
Department of Pharmaceutical Technology – Departments – Faculty of Pharmacy
Prerequisites (in Czech)
aFAFT2_13 Pharmceutical Technology II && aFASF2_11 Social Pharmacy II
Course Enrolment Limitations
The course is only offered to the students of the study fields the course is directly associated with.
fields of study / plans the course is directly associated with
Abstract
This course aims to provide students with a comprehensive understanding of the pharmaceutical industry, including its organizational structure, key interrelationships, and the specific operations involved in drug production, quality assurance, and regulatory compliance.
Learning outcomes
After completing this course, the student will be able to:
- Characterize the basic parameters of the contemporary pharmaceutical industry.
- Navigate relevant legal regulations and professional standards governing the pharmaceutical industry.
- Understand the fundamental relationships within the pharmaceutical industry ecosystem and their impact on drug availability and drug policy.
- Know the basic professional activities and their organization within a pharmaceutical manufacturing company.
Key topics
  • - The evolution and current state of the pharmaceutical industry
  • - Core functions of the pharmaceutical industry
  • - Legal regulations for drug manufacturing, professional and technical standards
  • - Drug research and development
  • - Technology transfer
  • - Environmental aspects of drug manufacturing
  • - Economic relationships in the pharmaceutical industry
  • - Issues of marketing, ethics, and corporate social responsibility in the pharmaceutical industry
  • - National and international organizations of drug manufacturers and distributors
Study resources and literature
    recommended literature
  • European Pharmacopoeia
  • LO, Andrew W. and Shomesh E. CHAUDHURI. Healthcare finance: modern financial analysis for accelerating biomedical innovation. Princeton: Princeton University Press, 2023, xxvii, 390. ISBN 9780691183824. info
  • MILLER, Susan; Walter MOOS; Barbara H. MUNK; Stephen MUNK; Charles HART and David SPELLMEYER. Managing the drug discovery process : insights and advice for students, educators, and practitioners. Second edition. Cambridge, MA: Elsevier, 2023, xlii, 639. ISBN 9780128243046. info
  • HILL, Ray G. and Duncan B. RICHARDS. Drug discovery and development : technology in transition. 3rd edition. [Edinburgh?]: Elsevier, 2022, ix, 373. ISBN 9780702078040. info
  • KELLY, William N. Pharmacy : what it is and how it works. Fourth edition. Boca Raton, FL: CRC Press, 2018, xxi, 397. ISBN 9781138038332. info
Approaches, practices, and methods used in teaching
Lectures
Method of verifying learning outcomes and course completion requirements
Combined examination
Language of instruction
English
  • Permalink: https://is.muni.cz/course/pharm/spring2026/aFAPF1_13